HBAR’s current price is $0.092974, down 7.25% over 24 hours and 13.64% over seven days. The price is close to the $0.091804 daily low and well below the $0.100312 high, showing pronounced recent weakness within the reported period.

The hourly moving averages are all above the current price: the 8-hour SMA is $0.0931, while the 13-, 21-, 55-, and 144-hour SMAs rise to $0.1012. This configuration is a bearish signal, and the increasingly large gaps to the longer averages indicate that the decline extends beyond the shortest hourly trend.

The 1-hour RSI of 25 signals oversold conditions, which can be consistent with a short-term bounce but does not itself confirm a reversal. The 7-day RSI of 43 is less extreme and does not provide a strong counter-signal to the recent price declines.

Momentum is mixed across timeframes: HBAR is down 13.64% over seven days but up 2.39% over 14 days and 12.62% over 30 days. Those longer-period gains show that the recent drop has followed positive performance, yet the sharp seven-day loss suggests momentum has deteriorated materially; the data do not establish that the longer-term advance has resumed.

Reported 24-hour volume is 128,797,986, with volume equal to 3.15% of market capitalization. Without comparative volume data, this cannot establish whether selling activity is unusually strong or weakening, so it adds limited direction to the price and technical signals.

The overall rating is Hold. Short-term evidence is notably bearish: the 24-hour and seven-day losses, price near the daily low, and trading below every listed hourly moving average outweigh the limited reassurance from the oversold 1-hour RSI.

The rating is not Sell because the 14-day and 30-day changes remain positive, and an RSI of 25 leaves room for a short-term rebound. However, those factors are not sufficient to support a Buy while price remains below all listed hourly averages and the latest weekly move is sharply negative.

The primary evidence for Hold is this conflict between a weak near-term trend and positive 14- and 30-day returns, with the balance currently tilted bearish. A sustained improvement in price relative to the listed moving averages is not shown in the supplied data, so there is no clear confirmation that selling pressure has ended.